Literature DB >> 15811121

Comparison of benign keratoses using p53, bcl-1, and bcl-2.

Christine J Ko1, Peter Shintaku, Scott W Binder.   

Abstract

While cell-cycle markers have been used to differentiate benign vs. malignant lesions and to classify malignant lesions, benign keratoses have not been well studied using such markers. We hypothesized that inflammation or irritation of benign keratoses may be related to a shift in the cell cycle. We compared the immunohistochemical staining patterns of 10 seborrheic keratoses (SKs), 10 inflamed seborrheic keratoses (iSKs), and 10 inverted follicular keratoses (IFKs) using antibodies to p53, bcl-1, and bcl-2. Staining with antibodies to p53 was slightly increased in IFKs compared with iSKs or non-inflamed seborrheic keratoses. Bcl-1 staining was similar in all lesions. A population of bcl-2-positive dendritic cells was seen within the epidermal portion of IFKs. Keratinocyte bcl-2 staining was significantly higher in SKs compared with the other two keratoses. Bcl-2 may be increased in SKs as an anti-apoptotic mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811121     DOI: 10.1111/j.0303-6987.2005.00328.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

1.  Apoptosis in seborrheic keratoses: an open door to a new dermoscopic score.

Authors:  Olga Simionescu; Bogdan Ovidiu Popescu; Mariana Costache; Emilia Manole; Stefan Spulber; Mihaela Gherghiceanu; Andreas Blum
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

2.  Seborreic keratosis with Bowenoid transformation.

Authors:  A Shankar; Shaista Choudhary; Y A Manjunatha
Journal:  Indian Dermatol Online J       Date:  2012-09

3.  Keratinocytic Malfunction as a Trigger for the Development of Solar Lentigines.

Authors:  Marjam Jeanette Barysch; Ralph Peter Braun; Isabel Kolm; Verena Ahlgrimm-Siesz; Rainer Hofmann-Wellenhof; Christine Duval; Emilie Warrick; Francoise Bernerd; Stéphanie Nouveau; Reinhard Dummer
Journal:  Dermatopathology (Basel)       Date:  2019-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.